3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
10
Non-Muscle Invasive Bladder Neoplasms
6
Peritoneal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Transitional Cell
3
Appendiceal Neoplasms
3
Anus Neoplasms
2
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Peritoneal Diseases
1
Ovarian Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Necrosis
1
Male Urogenital Diseases
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Female Urogenital Diseases
1
Anal Canal Carcinoma
1
Interventions
Specimen Handling
6
pembrolizumab
4
enfortumab vedotin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
3
cabozantinib
2
Nivolumab
2
Carboplatin
2
Biopsy
2
relatlimab
1
eribulin
1
erdafitinib
1
avelumab
1
atezolizumab
1
Watchful Waiting
1
Standard of Care
1
Practice Guidelines as Topic
1
Plasmapheresis
1
Plasma Exchange
1
Observation
1
Lenalidomide
1
Ipilimumab
1
Doxorubicin
1
Cystoscopy
1
Contrast Media
1
Cisplatin
1
Central Venous Catheters
1
CTLA-4 Antigen
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ureteral Neoplasms
×
Mitomycin
×
90 days
×
Clear all
No trials found.